CAS: 1637443-98-1
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | hVEGF-IN-1 REF: IN-DA01DUA9CAS: 1637443-98-1 | 98% | To inquire | Thu 23 Jan 25 |
 | hVEGF-IN-1 REF: TM-T4288CAS: 1637443-98-1 | 100% - 98.85% | 62.00 €~2,004.00 € | Thu 30 Jan 25 |
 | hVEGF-IN-1 REF: 3D-MQC44398CAS: 1637443-98-1 | Min. 95% | To inquire | Thu 06 Mar 25 |
Ref: IN-DA01DUA9
| 25mg | 152.00 € | ||
| 50mg | 257.00 € |
Estimated delivery in United States, on Thursday 23 Jan 2025
hVEGF-IN-1
CAS:1637443-98-1
hVEGF-IN-1 inhibits human VEGF-A translation and has antitumor activity.
Formula:
C34H43N7O2
Purity:
100% - 98.85%
Color and Shape:
Solid
Molecular weight:
581.75
- Quinazoline
- Inhibitors
- Tyrosine Kinase/Adaptors
- VEGFR
- See more categories
- Quinazoline and Impurities
Ref: TM-T4288
| 1mg | 62.00 € | ||
| 5mg | 126.00 € | ||
| 10mg | 173.00 € | ||
| 25mg | 291.00 € | ||
| 50mg | 421.00 € | ||
| 100mg | 588.00 € | ||
| 200mg | 794.00 € |
Estimated delivery in United States, on Thursday 30 Jan 2025
hVEGF-IN-1
Controlled ProductCAS:1637443-98-1
hVEGF-IN-1 is a recombinant human vascular endothelial growth factor (VEGF) that has been shown to …
Formula:
C34H43N7O2
Purity:
Min. 95%
Molecular weight:
581.75 g/mol
Ref: 3D-MQC44398
| 25mg | 1,004.00 € | ||
| 50mg | 1,314.00 € | ||
| 100mg | 2,102.00 € |
Estimated delivery in United States, on Thursday 6 Mar 2025
